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Abstract:  Phospholipase  A1  (PLA1)  is  an  enzyme  that  hydrolyzes  phospholipids  and 
produces 2-acyl-lysophospholipids and fatty acids. This lipolytic activity is conserved in a 
wide range of organisms but is carried out by a diverse set of PLA1 enzymes. Where their 
function is known, PLA1s have been shown to act as digestive enzymes, possess central 
roles in membrane maintenance and remodeling, or regulate important cellular mechanisms 
by the production of various lysophospholipid mediators, such as lysophosphatidylserine 
and lysophosphatidic acid, which in turn have multiple biological functions. 
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1. Introduction 
 
Phospholipases  form  a  diverse  class  of  enzymes  optimized  to  hydrolyze  phospholipid  (PL) 
substrates at specific ester bonds. Phospholipases vary considerably in structure and function, and as 
such  they  are  assembled  as  a  group  solely  on  the  basis  that  they  are  lipolytic  enzymes  involved  
in  PL  metabolism.  Two  general  sets  of  phospholipases  exist,  the  acyl  hydrolases  and  the 
phosphodiesterases; and the enzymes within each set are classified according to the cleavage of the 
ester bond for which they are specific (Figure 1). Phospholipase A1 (PLA1), phospholipase A2 (PLA2), 
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phospholipase  B  (PLB),  and  lysophospholipase  A1/2  (LysoPLA1/2)  constitute  the  acyl  hydrolases, 
whereas the phosphodiesterases are represented by phospholipase C (PLC) and phospholipase D (PLD). 
Phospholipases exist in almost every type of cell analyzed for their presence and most cells contain 
a multitude of them. For a given PL ester bond, there can be a variety of subtypes of a phospholipase 
that are specific for it that can either exist as secreted, membrane associated, or in cytoplasmic form. 
They  may  also  require  cofactors  for  activity,  depending  on  the  isoforms.  The  functions  of 
phospholipases, where known, are as varied as their cellular and tissue localization and properties. 
Nonetheless, three general functions can be ascribed to the physiologic relevance of phospholipases: 
(1) they can serve as digestive enzymes, e.g., PLA are ubiquitous in snake and vespid venoms; (2) they 
can play an important role in membrane maintenance and remodeling,  i.e., fatty acid (FA) chains  
of  PLs  can  be  cleaved  and  exchanged  by  an  acyl  hydrolase  and  an  acyltransferase,  respectively;  
and (3) they can regulate important cellular mechanisms, e.g., creation of bioactive lipid molecules 
used in signal transduction. These three areas of function can be a rather simplistic view accepting 
that,  for  example,  maintaining  acyl  composition  of  membranous  PLs  can  be  considered  quite  an 
important regulatory function for the cell, even though the reason that cellular membranes require a 
heterogeneous mixture of PL fatty acids is still not fully understood [1]. These three themes will be 
explored in more detail in subsequent sections. 
Among the different sorts of phospholipases, the most studied and well understood are PLA2, PLC, 
and  PLD,  all  of  which  play  proven  important  roles  in  the  creation  of  bioactive  lipid  molecules. 
Although this review will focus on PLA1, a brief overview of the other phospholipases and their 
biological significance will also be given to gain perspective. 
Figure 1. Ester Bond Specificity of the Phospholipases. PLA1, PLA2, and PLC catalyze the 
hydrolysis of the ester bond emanating from the sn-1(1), sn-2 (2), and sn-3 (3) carbon, 
respectively. PLD hydrolyzes the other phosphodiester bond. PLB cleaves both the sn-1 
and sn-2 ester bonds. * = LysoPLA can either be specific for the sn-1 or sn-2 bond, or both, 
when one or the other acyl chain is missing. R1 and R2, (CH2)nCH3; R3, various headgroups. 
 
1.1. Phospholipase A1  
 
PLA1 (EC 3.1.1.32) catalyzes the hydrolysis of FAs exclusively at the sn-1 position of PLs. A free 
fatty acid (FFA) and a lysophospholipid (lysoPL) are the products of a PLA1 reaction (Figure 2). This Int. J. Mol. Sci. 2011, 12                       
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class of phospholipase is not well understood, and no crystal structures exist for any true PLA1 [2,3]. 
The  assignment  of  a  function  for  any  PLA1 from  any  organism  has  yet  to  be  firmly  established. 
Historically, the biological role of this acyl hydrolase was often defined by its anticipated participation 
in the Lands Cycle, which is a deacylation-reacylation cycle that PLs are suspected to undergo in order 
to  remodel  their  acyl  chains  to  preserve  a  homeostatic  molecular  species  composition  of  PLs  in 
membrane  bi-layers  [4].  However,  only  one  PLA1  has  ever  been  directly  implicated  in  a  Lands  
Cycle [5], though this cycle has repeatedly been shown to occur at the sn-2 position via the action of 
PLA2, and studies continue to observe the phenomenon [6–10]. The assignment of a similar function 
for PLA1, though potentially valid, cannot be decuded based on experimental data. Understanding of 
these enzymes is limited, though some progress has been made over the past 20 years [11]. 
What is intriguing is the observation that despite a theoretical role in the Lands Cycle, none of the 
PLA1 cloned and characterized have been linked to membrane turnover and remodeling roles. On the 
contrary, there is some evidence to suggest that some PLA1 enzymes are virulence factors [12] or act to 
generate  bioactive  lysoPL  molecules.  For  example,  lysoPL  mediators  such  as  lysophosphatidic  
acid (lysoPA) [13] are second messenger signaling components in pathways that vary in complexity 
and  evolutionary  conservation,  and  they  have  been  implicated  in  numerous  processes  such  as 
proliferation,  protein  transport,  differentiation,  invasion,  and  morphogenesis  [14].  By  activating 
specific  G-protein  coupled  lysoPL  receptors,  they  are  now  viewed  as  key  factors  in  cell-to-cell 
communication  [15].  The  synthesis  and  regulation  of  the  formation  of  lysoPLs  are  not  fully 
understood, a reason why PLA1 is an important enzyme to study as it could be involved in their formation. 
The FA product from a PLA1 reaction also has bioactive potential. This has been shown in plants, 
where a PLA1 regulates jasmonic acid biosynthesis. Also, it has been postulated for decades that sn-2 
arachidonic  acid  (AA)  cleavage  from  PLs  may  sometimes  be  mediated  by  concerted  sequential 
PLA1/LysoPLA2 activities [16–24]. No cloned PLA1 has been implicated in this alternative route, and 
therefore it remains circumstantial with regards to the in vitro studies, which provide the most indirect 
evidence [16,22,23]. 
 
1.2. The Other Acyl Hydrolases: Phospholipase A2, B, and Lysophospholipase 
 
PLA2 (EC 3.1.1.4) mediates acyl ester hydrolysis at the sn-2 position of PLs. PLA2 are quite well 
conserved across taxa, and they consist of a broad range of enzymes that segregate into one of eleven 
groups within the superfamily [25]. Numerous PLA2 can contribute to lysoPL signaling events [26] 
and  can  even  down-regulate  the  bioactive  lysoPL  platelet  activating  factor  (PAF)  with  the  sn-2  
acetate-specific cleavage of PAF by PAF acetyl hydrolase (PAF-AH) [27]. However, PLA2 is most 
noted for its role in initiating the AA cascade (Figure 2) [28]. The sn-2 reacylation step of the Lands 
Cycle appears to be quite specific for AA in a number of cells [29]. Once liberated by a cytoplasmic 
PLA2, AA is converted into over 150 known eicosanoids, including prostaglandins, leukotrienes, and 
thromboxanes, all powerful local hormones that act as mediators in many important processes such as 
inflammation in the higher eukaryotes [30]. Numerous crystal structures exist in this class of enzymes 
whose active mechanism either utilizes a catalytic histidine in a so-called dyad or a catalytic serine in 
either a dyad or a triad [25,27,31]. 
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Figure 2. Regulatory Processes Linked to PL Metabolism. The phospholipases known to 
produce  bioactive  lipid  molecules  are  shown  in  blue,  and  their  second  messenger 
metabolites, or their signal-transduced responses, are boxed. Other enzymes utilized in PL 
and FA metabolism are in red. DAG, diacylglycerol; IP3, inositol(1,4,5)phosphate; PKC, 
protein kinase C; AA, arachidonic acid; LO, lipoxygenase; COX 1,2, cyclooxygenase 1 
and 2; PG, prostaglandin; FFA, free fatty acid; CoA, coenzyme A; PLC, phospholipase C; 
cPLA2,  cytoplasmic  phospholipase  A2,  PLD,  phospholipase  D;  PA-PLA1,  phosphatidic 
acid  phospholipase  A1;  PLA1,  phospholipase  A1,  LysoPLA1,  lysophospholipase  A;  
ACS, acyl-CoA synthetase; PA, glycerophosphatidic acid; PC, phosphatidylcholine; PI, 
phosphatidylinositol. * = theoretical pathway based on indirect in vitro evidence. 
 
 
PLB  is  able  to  hydrolyze  both  the  sn-1  and  sn-2  FAs  of  PLs  (Figure  1).  Glycosylation  is  a  
common  feature  of  PLBs,  such  as  the  one  from  Penicillium  notatum,  which  contains  numerous  
asparagines-linked  carbohydrates  and  possess  phospholipase  and  subsequent  lysophospholipase 
activity [32]. The distinction between PLB and LysoPLA can, rightly so, often be muddled since most 
PLBs  possess  lysophospholipase  activity [33].  On the other  hand,  some PLB  enzymes  have been 
erroneously annotated. For example, a case in which a purified hamster heart cytosol enzyme clearly Int. J. Mol. Sci. 2011, 12                       
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displayed both sn-1 and sn-2 hydrolysis has been referred to as a PLA [34]. Also, the first so-called 
PLA1 to be purified, cloned, and crystallized was the outer-membrane phospholipase A (OMPLA) 
from E. coli and other bacteria [35–37], but it has been known for a long time that it can cleave at both 
positions sn-1 and sn-2 of diacyl- or lysoPLs and thus should be considered a phospholipase B [2,24]. 
LysoPLA  (EC  3.1.1.5)  detoxifies  detergent-like  lysoPL  intermediates  in  PL  metabolism  by 
removing the remaining acyl chain from the lysoPL (Figure 1). This class of enzymes is also not well 
characterized. LysoPLA could also be important in the regulation of the amount of bioactive lysoPLs 
used in receptor-mediated or other signaling mechanisms [38]. Some LysoPLA can function equally 
well as either a LysoPLA1 or a LysoPLA2 [17]. Other LysoPLA can deacylate specific species of 
lysoPL, like those with AA esterfied to the sn-2 position, for example [18,39]. Such in vitro specificity 
has helped to fuel the theory that the AA cascade could be initiated by the combined actions of a PLA1 
and a LysoPLA2. 
 
1.3. The Phosphodiesterases: Phospholipase C and D 
 
PLC or PI-PLC (EC 3.1.4.11) is mostly known for catalyzing the cleavage of the phosphorylated 
membrane lipid PI to produce, for example, the intracellular second messengers sn-1,2-diacylglycerol [23] 
and inositol (1,4,5)-trisphosphate (Figure 2). The phosphoinositides are a critically important class of 
PLs  which  have  been  extensively  researched,  along  with  the  mechanisms  by  which  they  are 
metabolized by PLC [40]. PLC-mediated phosphoinositide production is a key regulating component 
of ion channels and transporters,
 and controllers of vesicular trafficking and the transport of
 lipids 
between intracellular membranes [41]. Other types of PLC include a secreted form in bacteria that 
prefers PC (E.C. 3.1.4.3), and a GPI-PLC form found in various organisms that specifically recognises 
non-inositol-acylated glycosylphosphatidylinositol anchors. 
PLD (EC 3.1.4.4) hydrolyzes the sn-3 phosphodiester bond of mostly PC to generate a choline 
molecule and PA. PLD has also been studied in detail due to its link with the production of PA, an 
intracellular lipid messenger implicated in almost every conceivable aspect of intracellular membrane 
transport [42]. PLD is also a potential regulator of lyso-PA formation, whose biosynthetic formation is 
unclear, but could involve both PLD and PLA1 [43]. The mode of action and structural characteristics 
of the various isoforms of PLD are well characterized [42,44]. 
 
2. Classification of Phospholipase A1 
 
Over one hundred years ago accumulation of FFAs was observed upon incubation of pancreatic 
juice with phosphatidylcholine (PC), and the existence of enzymes responsible for the release of these 
acids was accordingly proposed. Snake venoms were also found to possess PL-hydrolyzing enzymes 
when in 1903 cobra venom was found to alter PC into products, which could cause red blood cell 
hemolysis. These products were later determined to be a PC molecule that was missing a FA, and they 
were  thus  termed  lysophosphatidylcholine  (lyso-PC).  Only  in  the  early  1960’s  however  was  the 
positional specificity of FA cleavage of snake venom determined to be the sn-2 position of the glycerol 
backbone of PLs [44]. Early on, therefore, the study of PLA activity focused on PLA2 activity, as it has 
remained to this day. Nevertheless, phospholipases of type A were linked to those enzymes cleaving Int. J. Mol. Sci. 2011, 12                       
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FAs from PLs, and the designation A1 and A2 was employed to signify the acyl hydrolysis from either 
the sn-1 or sn-2 position of the glycerol moiety, respectively [45]. It wasn’t long before intracellular 
PLA activities were beginning to be discovered in numerous organisms and tissues, thus opening the 
way for the possibility that these enzymes were more than just digestive catalysts. 
PLA1 specifically hydrolyzes sn-1 acyl esters from PLs producing FFAs and lysoPLs (Figure 2). 
However,  many  PLA1  enzymes  exhibit  some,  usually  much  lower,  LysoPLA  activity  and  neutral 
lipase activity (i.e., hydrolyzing diacylglycerol or triacylglycerol), yet still preferring the sn-1 cleavage 
site. Enzymes having high PLA1 relative to LysoPLA and neutral lipase activity are thus considered 
true PLA1 enzymes, and they can only be designated as such by empirical determination after some 
level of purification or, more preferably, by cloning and characterization of the recombinant enzyme. 
The vast amount of results from early studies involving the detection of PLA activity from crude tissue 
or subcellular fractions were flawed due to the inability to precisely determine what enzyme activities 
are  present  and  how  to  differentiate  particular  enzyme  activities.  Competing  and/or  downstream 
enzyme activities on lipid substrates can mask the activity of the enzyme being tested. 
PLA1  enzymes  have  not  been  formally  classified  into  groups,  as  have  the  other  major 
phospholipases. The major obstacle is the lack of available sequence due to only a relatively small 
proportion of PLA1 enzymes having been cloned thus far (Table 1). The only invariable feature of 
PLA1 seems to be a lipase consensus motif in the peptide sequence, which follows the amino acid 
residue  pattern  [LIV]-{KG}-[LIVFY]-[LIVMST]-G-[HYWV]-S-{YAG}-G-[GSTAC],  inside  of 
which resides a common GXSXG motif, containing the catalytic serine of the active site, as part of a 
catalytic triad. 
PLA1 has been considered as a descendent of neutral lipases, and several PLA1 sequences show 
substantial  sequence  similarity  to  the  well  characterized  pancreatic,  hepatic,  and  endothelial  
lipases [43,46,47]. Other PLA1 sequences show no similarity to lipase sequences beyond their lipase 
consensus  pattern, nor do they show similarity to  other PLA1 sequences.  Furthermore, eukaryotic 
lipases possess two domains whereas prokaryotic lipases only contain one, in which there is little if 
any conservation in sequence (compare alignments in [48–51]. Int. J. Mol. Sci. 2011, 12                       
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Table 1. The Phospholipase A1 Family 
1. 
Classification  Organism    Name 
2  Location  Cellular 
Localization 
~ Size (kDa)  Substrate 
Specificity 
Catalytic 
Properties 
Reference 
Eukarya                   
Animali:  Bos taurus  □  PA-PLA1  Testis, Brain  Cytosolic  98  PA  SXSXG catalytic 
serine
3 
[52,53] 
  Mus musculus  □  p125  Ubiquitous  Cytosolic  111  nd
4  GXSXG motif  [54] 
  Homo sapiens  □  KIAA0725p  Ubiquitous  Cytosolic  81  PA, PE  GXSXG catalytic 
serine
3 
[55] 
  Homo sapiens  ●  mPA-PLA1α  Various tissues  Secreted  58  PA  Catalytic triad
5  [43,56] 
    ●  mPA-PLA1β  Reproductive tissues  Mem-Ass  58  PA  Catalytic triad
5  [43,56] 
      PLRP2            [50] 
  Rattus 
norvegicus 
●  PS-PLA1  Platelets+various   Secreted  55  PS, lysoPS  Catalytic triad
5  [46,48,57] 
  Dolichovespula 
maculate 
●  Dol m I  Venom sac  Secreted  34  nd
4  Catalytic triad
5  [47] 
  Vespula spp.  ●  Ves v I  Venom sac  Secreted  34  nd
4  Catalytic triad 
5  [58–60] 
    ●  Ves m I  Venom sac  Secreted  34  nd
4  Catalytic triad 
5  [58–60] 
  Caenorhabditis 
Elegans 
  IPLA-1    ER  87  PI  Catalytic triad 
5  [5] 
Plantae:  Arabidopsis 
thaliana 
  DAD1  Anthers  Chloroplast  45  PC
6  GXSXG motif  [61] 
      AtLCAT3  nd
4  Microsomes  46  PC, PE, PA   SXSXG-catalytic 
triad
3 
[62,63] 
Fungi:  Aspergillus 
oryzae 
  AoPLA1  n/a
4  Secreted  36  nd
4  GXSXG motif  [64] 
  Thermomyces 
lanuginosus 
    n/a
4  nd
4    PC    [65] 
Protozoa:  Trypanosoma 
brucei 
  TbPLA1  n/a
4  Cytosolic  34  PC  GXSXG catalytic 
serine 
3 
[49,66] Int. J. Mol. Sci. 2011, 12                       
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Table 1. Cont. 
Prokarya                   
Bacteria:  Serratia spp.  ♦  PhlA  n/a  Secreted  34  nd
4  GXSXG motif  [67,68] 
    ♦  PlaA  n/a  Secreted  34  nd
4  GXSXG motif  [69] 
  Yersinia 
enterocolitica 
♦  YplA  n/a  Secreted  34  nd
4  GXSXG motif  [70] 
1 Only those PLA1 which have been cloned and reported in the literature have been included; 
2 Homologues are represented with the same symbol. 
Abbreviations  are:  PA-PLA1,phosphatidic  acid-preferring  PLA1;  mPA-PLA1,  membrane-associated  phosphatidic  acid-selective  PLA1;  PS-PLA1; 
phosphatidylserine-specific PLA1; DAD1, defective in anther dehiscence 1; AtLCAT3, Arabidopsis thaliana lecithin:cholesterol acyltransferases; SGR2, 
shoot gravitropism 2; PhlA, Serratia liquefaciens PLA1; PlaA, Serratia spp. MK1 PLA1; YplA, Yersinia enterocolitica; 
3 Empirically deduced; 
4 nd = not 
determined, n/a = not applicable; 
5 Deduced by similarity with its lipase homologues known to utilize a histidine, an aspartic Acid, and a GXSXG serine in a 
catalytic triad; 
6. The only substrate tested. 
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3. Mammalian Phospholipase A1 
 
A large number of crude protein preparations from mammalian cell and tissue homogenates were 
enriched for PLA1 activity in the 1970’s and 1980’s, but many of these reports describe PLA1 activity 
of uncertain origin. A good example of this is the characterization of a ―phospholipase A1‖ from the 
plasma  of  rat  liver  that  was  found  to  hydrolyze  triacylglycerols,  diacylglycerols,  and 
monoacylglycerols, in addition to PLs [71]. This ―phospholipase A1‖ was located on the surface of 
endothelial cells and was shown to play a role in high density lipoprotein metabolism, and two papers 
were published characterizing its ―phospholipase A1‖ activity. Interestingly, relatively recently a new 
member of the lipase family was cloned from endothelial cells and a recombinant form was shown to 
possess PLA1 activity [72]. Endothelial lipase most likely accounts for the majority of the PLA1 and 
lipase activities previously reported from enriched rat liver endothelial cell fractions. 
It us now generally accepted that mammals have six extracellular and three intracellular PLA1 
enzymes  [50].  The  extracellular  PLA1s  consist  of  phosphatidylserine  (PS)-specific  PLA1  (PS-PLA1), 
membrane-associated phosphatidic acid (PA)-selective PLA1s (mPA-PLA1α and mPA-PLA1β), these 
PLA1s may have physiological roles as they produce the lysophospholipids, lyso-PS and lyso-PA known 
to be lipid mediators with multiple biological functions. The other three extracellular enzymes are 
either  involved  in  high-density-lipoprotein  catabolism  of  triacylglycerol,  hepatic  lipase  (HL)  and 
endothelial lipase (EL), or digestion of dietary lipids, pancreatic lipase-related protein (PLRP)-2. These 
three enzymes belong to the lipase gene family showing triacylglycerol-hydrolyzing activity as well as 
PLA1  activity.  The  intracellular  PLA1s,  KIAA0725p  and  p125,  are  conserved  in  a  wide  range  of 
organisms and have been implicated in vesicular transport. 
 
3.1. Bovine Brain PLA1  
 
One of the first phospholipases of the type A1 to be purified by column chromatography was from 
bovine brain [21]. The enzyme was isolated from the soluble fraction and eluted at a molecular mass 
of 365 kDa from a Sephacryl S-300HR column. Lipases are known for their interfacial activation 
properties, and the 365 kDa molecular weight obtained could reflect the enzyme’s molecular weight 
upon association with buffer detergent micelles, or it could represent the enzyme in tetramer form. 
Bovine brain PLA1 migrated as two bands of 112 kDa and 95 kDa by SDS-PAGE. The purified 
enzyme was shown to be resistant to metal chelators, PMSF, and DFP, but it was inactivated by ZnCl2 
and enhanced by Ca
2+, Mg
2+ and Sr
2+. The enzyme exhibited broad substrate specificity in mixed 
micelles  made  with  CHAPS,  but  the  highest  specific  activity,  23.8  μmol/min/mg,  was  exhibited 
against PE(16:0/20:4), and LysoPLA1 activity was also observed. A subsequent study showed that PC 
and PI could also be catalyzed at a high rate by bovine brain PLA1 but only in the presence of other 
PLs like PS, PE, and PA [73]. This same group reported the first chromatographic purification of a 
LysoPLA2 that showed selectivity towards deacylating arachidonate from lyso-PC(−/20:4) [39]. In 
addition to its LysoPLA2 activity, this enzyme also showed PLA2 activity, but at a slower rate. Bovine 
brain LysoPLA2 was isolated from the soluble fraction and is an approximately 95 kDa polypeptide. 
Moreover, it became clear that prior sn-1 deacylation of PC(16:0/24:0) by bovine brain PLA1 greatly 
increased the rate of arachidonate deacylation by brain LysoPLA2. These results suggested that in Int. J. Mol. Sci. 2011, 12                       
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bovine brain AA might possibly be generated by sequential PLA1/LysoPLA2 action, yet this has never 
been shown in vivo. Even more, the physiological substrates for these two enzymes have never been 
determined  so  it  is  impossible  to  know  whether  arachidonoyl-substituted  PC  or  PE  are  in  fact 
hydrolyzed by these enzymes. Unfortunately, not knowing the in vivo physiological substrates is a 
recurring theme in PLA1 studies. It is also important to note that the genes encoding these two PLA 
activities have not been determined. 
 
3.2. Bovine Testis PA-PLA 
 
The phosphatidic acid-preferring phospholipase A1 (PA-PLA1) from bovine testis is well studied. 
The initial identification of PA-PLA1 was from Mono Q fractions of high-speed supernatants from 
bovine testis, and to a lesser extent in bovine brain [53]. The enzyme displayed preference for PA in 
TX-100  detergent  mixed  micelles,  and  it  also  displayed  a  relatively  small  amount  of  LysoPLA1 
activity.  At  the  time  of  its  identification,  PA  was  just  beginning  to  be  recognized  as  a  second 
messenger  that  could  affect  a  number  of  cellular  processes.  The  production  and,  particularly,  the 
attenuation of signaling PA can  be mediated  by multiple phospholipases  that regulate the timing, 
location,  amount,  and  various  molecular  species  of  PA  [74].  A  14,000-fold  purification  of  native  
PA-PLA1  was  achieved  and  evidence  was  provided  that  the  enzyme  was  a  homotetramer  of  
110 kDa subunits [75]. When the enzyme was examined under the same conditions as the bovine brain 
PLA1 previously reported (i.e., 3–5 mM MgCl2) [21], the results showed that PE(16:0/24:0) became 
the preferred substrate. When MgCl2 was removed, PA-PLA1 preference for GPA was restored. It is 
thus possible that the bovine testis PA-PLA1 and the bovine brain PLA1 are one and the same enzyme. 
Further studies eventually led to the cloning of bovine testis PA-PLA1, which was encoded by an 
875 amino acid protein with a predicted molecular mass of 97.6 kDa [52]. A ~2000 fold increase in 
PA-PLA1  activity  was  observed  when  the  protein  was  expressed  in  COS1  cells.  A  lipase-like 
consensus  sequence  was  identified  and  the  active  site  serine  residue  within  a  SXSXG  motif  was 
experimentally established as being essential for PA-PLA1 activity in the COS1 expression system. 
Apart  from  containing  a  lipase-like  consensus  motif,  the  PA-PLA1  sequence  differed  from  other 
lipases and phospholipases. Homologues were identified in the genomes of Caenorhabditis elegans, 
yeast, Drosophila, and in human and mouse. A homologue involved in shoot gravitropism has also 
been identified in A. thaliana [63]. Splice variants were proposed to possibly exist after three cDNAs 
were found that contained a 123-base deletion, and it was put forth that if splice variants had different 
substrate specificities, then the seeming discrepancy between the bovine brain and testis substrate 
specificities may be explained in this manner. A complex array of conditions were created to examine 
properties of purified PA-PLA1 [75] using an interface composed of unilamellar lipid mixed micelles [76]. 
In the end, catalytic preference for PA(16:0/18:1) was reported to be observed when the unilamellar 
micelles  contained  (i)  a  low  relative  amount  of  PC;  (ii)  high  relative  amounts  of  PE,  PS,  and 
cholesterol;  (iii)  DAG;  (iv)  PE(18:0/20:4)  instead  of  PE(16:0/18:1);  and  (v)  10  mol  %  PA  
per  100  mol  %  total  phosphoglycerides.  The  study  also  showed  that  PA-PLA1  could  bind  to 
membranes composed of anionic phosphoglycerides and could be stabilized by these membranes in the 
presence of albumin.  Int. J. Mol. Sci. 2011, 12                       
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Other experiments with PA-PLA1 provided information about the effects of phosphorylation and 
dephosphorylation  on  the  behavior  of  the  enzyme  [77].  The  first  splice  variant,  PA-PLA1α,  was 
recombinantly expressed in Sf9 cells and purified, though a homogeneous fraction of enzyme was not 
shown. The recombinant protein was shown by mass spectrometry to be phosphorylated by protein 
kinase CK2, with which it also formed complexes, and by extracellular signal-regulated kinase 2. They 
also  showed  that  protein  phosphatase  2A  could  dephosphorylate  some  of  the  phosphoryl 
modifications, which led them to raise the possibility that the native counterparts of these enzymes 
could  coordinately  regulate  the  phosphorylation  state  of  PA-PLA1  in  vivo.  The  physiological 
significance of PA-PLA1 still remains to debatably [50], because it is most highly expressed in testis it 
has been suggested that PA-PLA1 could be involved in PA signaling during spermiogenesis [74,76]. 
3.3. p125 and KIAA0725p 
 
Budding vesicles mediate transport of proteins between intracellular compartments.  One of the 
components of ER to Golgi COPII-coated vesicles of the secretory pathway is the Sec23p-Sec24p 
complex. In a study, that attempted to affinity isolate and identify new Sec23p-interacting proteins a 
novel  protein,  p125  (111  kDa),  was  identified.  The  predicted  peptide  sequence  of  p125  was 
homologous to bovine PA-PLA1 [54]. In addition, the N-terminal region of p125 contains a proline-rich 
region  that was shown  to  be  the functional region of the enzyme in its  association with  Sec23p. 
Detection  of  low  levels  of  recombinant  p125  expression  showed  co-localization  with  β-COP  and 
ERGIC53, an ER-Golgi intermediate compartment marker. In contrast, detection of high levels of 
p125 over-expression revealed p125 dispersed throughout the cells, not only in membranes, but also in 
the  cytosol,  causing  disorganization  of  the  ER-Golgi  intermediate  compartments.  ERGIC-53  also 
showed a dispersed staining pattern in these cells, and a second type of staining showed that the Golgi 
itself was dispersed. p125 was also shown to co-localize with p115 and GM130 proteins [78], both of 
which play a role in vesicle tethering to Golgi membranes [79]. Depletion of p125 by RNAi suggested 
that p125 is needed for the proper organization and distribution of ER exit sites; however, p125-depleted 
cells maintained regular rates of protein transport from the ER [80]. Despite these detailed studies, no 
examination  of  stereo-specific  enzyme  activity  was  undertaken,  so  p125  may  indeed  not  even  
be a PLA1. 
However, another protein, KIAA0725p, has also been identified as a homologue of both bovine 
PA-PLA1  and  p125  [55].  KIAA0725p  is  ubiquitously  expressed  in  mammalian  cells  and  is 
predominantly  localized  in  the  cytoplasm.  Consistent  with  its  bovine  PA-PLA1  homologue, 
KIAA0725p preferentially cleaves the sn-1 ester linkage of PA; however, in the absence of detergent it 
also hydrolyzed PE. PA specificity was determined using homogenates of KIAA0725p-expressing 
cells, and homogenates with the GXSXG seryl residue mutated to alanine showed no PLA1 activity. 
Like p125, results showed that over-expression of KIAA0725p in cultured cells provoked dispersion of 
ERGIC53 and β-COP; but, unlike p125, over-expression also caused dispersion of p115 and GM130. This 
morphological phenotype was not due to PLA1 activity because over-expression of the lipase-inactive 
mutant caused the same phenotype. However, over-expression of KIAA0725p, but not its lipase-inactive 
mutant, also caused aggregation of the ER, which was thus determined to be dependent on PLA1 
activity. The authors proposed that KIAA0725p may promote fusion of ER membranes by changing Int. J. Mol. Sci. 2011, 12                       
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cone-shaped PA to inverted-cone shaped lyso-PA, which has been suggested to promote fusion pore 
formation, the last step of membrane fusion [81]. Recently it has been shown that the isoform iPLA(1) 
g is a novel membrane transport factor that mediates a membrane transport pathway between the ER 
and the Golgi that is distinct from the previously characterized COPI- and Rab6-dependent pathways [82]. 
 
3.4. PS-PLA1 
 
A novel PLA1 secreted from rat platelets was the first PLA1 discovered which preferentially cleaves 
FAs from PS [46]. The predicted peptide sequence from the cloned cDNA of PS-PLA1 was found to 
show  significant  sequence  homology  to  hepatic  lipase,  lipoprotein  lipase,  pancreatic  lipase,  and 
endothelial  lipase,  but  the  enzyme  does  not  possess  appreciable  neutral  lipase  activity.  The  
enzyme  was  partially purified  by  sequential  column  chromatography  from  the  culture  medium  of 
thrombin-activated platelets, and from medium of insect Sf9 cells expressing recombinant PS-PLA1 in 
a baculovirus system. The resulting enzyme was shown to be a 50–55 kDa protein that was equally 
active towards PS and lyso-PS. PS-PLA1 is also believed to be a glycoprotein. Due to its sequence 
similarity  with  lipases,  the  primary  PS-PLA1  peptide  sequence  reveals  that  is  has  a  β-9  loop  
and  a  lid  domain;  but  PS-PLA1  has  shorter  versions  of  each  [46],  which  could  explain  why 
diisopropylphosphofluoridate (DFP) inhibits  this enzyme,  if the truncated lid domain ineffectively 
covers the active site serine. A subsequent study revealed that PS-PLA1 might be the synthetic route in 
the production of bioactive lyso-PS since it was shown that it has the ability to efficiently stimulate 
histamine release from rat peritoneal mast cells, especially when in the presence of apoptotic Jurkat 
cells [83]. In this system, 2-acyl-1-lysoPS was released from apoptotic cells exposed to PS-PLA1 and it 
was proposed that PS-PLA1 may play an in vivo role in hydrolyzing PS exposed on plasma membranes 
of apoptotic, dead, and cytokine-stimulated cells, as a means to transduce mast cell activation mediated 
by  2-acyl-1-lysoPS.  PS-PLA1ΔC,  a  splice  variant  of  the  human  version  of  PS-PLA1,  shows  poor 
catalytic activity towards PS and the other diacylPLs but is able to deacylate lyso-PS effectively and is 
therefore a LysoPLA [84]. PS-PLA1ΔC possesses a truncated C-terminal region; therefore peptides on 
the complete C-terminal domain of PS-PLA1 are thought to play a role in substrate recognition. In a 
very recent study PS-PLA1  expression in  human  THP-1-derived macrophages,  responsible  for  the 
immune responses to allograft rejection, are activated via TLR4. This activation can be inhibited by 
corticosteroids, which are used at high dosages to suppress chronic allograft rejection [57]. 
 
3.5. mPA-PLA1 
 
A  sequence  similarity  search  of  the  PS-PLA1  detected  another  PLA1  enzyme  which  was 
homologous  to  neutral  lipases,  that  of  membrane-associated  phosphatidic  acid-selective 
phospholipase A1 alpha and beta (mPA-PLA1α/β) [43,56]. Both recombinant forms show PA-specific 
substrate specificity. Attempts to purify the recombinant membrane proteins from Sf9 cells failed but 
medium from mPA-PLA1α-expressing cells was shown to activate a lyso-PA receptor family member, 
LPA3/EDG7. Medium from cells expressing an active site serine mutant failed to induce a receptor 
response. These results indicated that cells expressing recombinant mPA-PLA1α were able to produce 
and release bioactive lyso-PA. When expressed in HeLa cells mPA-PLA1α was recovered from the Int. J. Mol. Sci. 2011, 12                       
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cell  supernatant  whereas  mPA-PLA1β  was  still  membrane  associated  [56].  A  set  of  elegant 
experiments also showed that mPA-PLA1α/β acted after and in concert with both endogenous and 
exogenous PLD to form lyso-PA. This report thus suggests a possible in vivo metabolic pathway for 
lyso-PA  production  involving  the  sequential  action  of  a  PLD  and  mPA-PLA1α/β.  Thus,  both  
PS-PLA1 and  mPA-PLA1α/β  thus  have  evolved  from  lipases  to  specialize  in  producing  bioactive  
lyso-PL mediators [5]. 
 
3.6. Guinea-Pig Heart Microsomal PLA1 
 
It has been reported that microsomes from guinea-pig heart possess PLA1 activity on PE and PC, 
and  that  sn-1  cleavage  could  be  influenced  by  the  sn-2  FA  since  more  efficient  hydrolysis  was 
observed when the sn-2 FA was polyunsaturated [85]. The enzyme(s) responsible for PLA1 activity 
from guinea-pig heart microsomes have not been identified and purified to any extent other than into 
subcellular  fractions,  but  a  few  studies  are  worth  mentioning  since  they  are  devoted  to  possible 
regulatory mechanisms of PLA1 activity in this tissue, and very few other studies exist that begin to 
explain how some PLA1 activity could be controlled. No PLA1-activating agonists are known, so a 
possibility that PLA1 could be receptor activated by G-proteins was investigated by measuring the 
response of PLA1 activity towards guanine nucleotides, which can activate G-proteins. PLA1 activity 
towards PC(16:0/18:2) was partially inhibited by guanosine 5'-[γ-thio]triphosphate (GTP[S]), but not by 
GTP,  guanosine  5'-[γ-thio]diphosphate  (GDP[S]),  GDP,  ATP  or  adenine  5'-[γ-thio]diphosphate 
(ATP[S]) [86]. On the other hand, PLA1 activity on PE(16:0/18:2) was stimulated by GTP[S] but not 
GDP[S] or ATP[S] [86]. PE(16:0/18:2) hydrolysis by guinea-pig heart microsomes was also shown to 
be stimulated 40–60% by isoprenaline. It has still yet to be shown in vivo if PLA1 activity in guinea-pig 
heart microsomes is activated by the binding of isoprenaline to adrenergic receptors and mediated via 
activation of G-proteins. Without either the purification or cloning of the enzymes responsible for this 
activity in guinea-pig heart microsomes, it is unlikely that any resolution of the issue will be made. It 
is worth recalling, however, that a ubiquitously expressed mammalian PA-PLA1 homologue, p125, is 
localized to the ER and interacts with Sec23p, which acts as a GTPase-activating protein that plays a 
role in uncoating budding vesicles [87]. Whether these PLA1 activities are due to the same or different 
enzymes is unknown, but it does stress the importance of how substrate specificity is analyzed in vitro, 
and the caution with which to interpret such data. To confuse the situation even further, guinea-pig 
heart microsomes were also shown to possess a LysoPLA2 that could hydrolyze lyso-PC(−/18:2 or 
20:4) more efficiently than lyso-PC(−/18:1 or 16:0) [18].This result lent some support to the standing 
possibility  that  arachidonic  and  linoleic  acids  could  be  released  by  LysoPLA2  acting  in  concert  
with a PLA1.  
 
4. Other PLA1  
 
PLA1 is a ubiquitous enzyme found in nearly every cell where it has been sought, and this includes 
metazoan and protozoan parasites, and snake venoms. 
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4.1. Caenorhabditis elegans PLA1 
 
The  Caenorhabditis  elegans,  IPLA-1  and  ACL-10  have  phospholipase  A1  and  acyltransferase 
activity respectively,
 both of  which  recognize  the  sn-1 position of their PI  substrate  [88].  The PI  
sn-1  fatty  acid  remodeling  by  sequential  deacylation  and  reacylation,  which  resulted  in  stearic  
acid as the major fatty acid at the sn-1 position, has been proposed to be crucial for asymmetric  
division [5]. 
 
4.2. Venom PLA1 
 
The cDNA of one allergen component of Dolichovespula maculate (white-faced hornet) venom has 
been cloned and shown to encode a PLA1 (Dol m I) with weak lipase activity [47]. In fact, at the time 
of the study, the derived peptide sequence of Dol m I had no homology to other PLA1 genes because it 
was similar to mammalian lipases. Now, not only is Dol m I 40% identical to pancreatic, hepatic, 
lipoprotein, and endothelial lipase, but it also shows homology with PS-PLA1 [46] and mPA-PLA1 [43]. 
Characterization of the 34–37 kDa enzyme has not been undertaken presumably due to a priority 
interest in understanding its immunochemical properties as it relates to its contribution to allergenicity. 
Along these same lines, two homologues of Dol m I have been cloned from Vespula spp. (yellow 
jacket)  (Ves  v  I  and  Ves  m  I)  which  show  67%  sequence  identity  with  the  white-faced  hornet  
PLA1 [58,59], and recent success in recombinant expression of PLA1 (Ves v I) from the yellow jacket 
will allow a more detailed understanding of the molecular and allergological mechanisms of insect 
venoms, providing a valuable tool for diagnostic and therapeutic approaches in hymenoptera venom 
allergy [60].  
 
4.3. Trypanosoma brucei PLA1  
 
The  PLA1/LysoPLA  theorized  coordinated  route  towards  the  release  of  unsaturated  FAs,  (e.g., 
arachidonic acid (AA)), has been supported by in vitro studies using homogenates from the kinetoplastid 
protozoan parasite Trypanosoma brucei, the infective agent of African sleeping sickness [23]. These 
studies observed robust and optimal activity at pH 6.0–8.5 and a requirement of sn-1 acyl cleavage 
prior to the release of AA from sn-1-palmitoyl-sn-2-arachidonoyl-sn-glycero-3-phosphatidylcholine 
[PC (16:0/20:4)] [89–91]. The liberated unsaturated FAs such as AA from lipids in T. brucei have 
been  implicated  in  regulating  calcium  mobilization  [92,93],  and  as  a  precursor  for  prostaglandin 
biosynthesis [94]. 
Two recent detailed studies describe the cloning and characterization of the cytosolic T. brucei 
PLA1. TbPLA1 is unique from other eukaryotic PLA1 because it is phylogenetically related to bacterial 
secreted PLA1 [49,66]. TbPLA1 was most likely acquired by a prokaryotic-to-eukaryotic horizontal 
gene transfer event of a PLA1 from Sodalis glossinidius, a bacterial endosymbiont of the insect vector 
of the protozoan parasite, the tsetse fly. These studies employed both in vitro and in vivo analytical 
techniques  to  establish  that  PC  is  the  preferred  substrate.  The  TbPLA1  homozygous  null  mutants 
constitute the  only  PLA1  double knockouts from any  organism and helped  to  established that the  
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enzyme  functions  in  vivo  to  synthesize  lyso-PC  metabolites  containing  long-chain  mostly 
polyunsaturated and highly unsaturated fatty acids. 
 
4.4. Trypanosoma cruzi PLA1  
 
One report described the existence of PLA1 activity in Trypanosoma cruzi, the etiologic agent of 
Chagas disease [95]. When trypomastigote and amastigote suspensions were radiolabeled with oleic 
acid and lysed, the radiolabeled PC content decreased over time. In addition, when PC(16:0/18:1) was 
incubated with epimastigote homogenates at pH 4.7, lyso-PC(−/18:1) was produced, suggesting sn-1 
hydrolytic  specificity.  T.  cruzi  PLA1  was  partially  purified  (1900-fold  by  specific  activity)  from 
epimastigote homogenate supernatants and a protein band of 38 kDa could be seen by SDS-PAGE, 
and size exclusion chromatography suggested PLA1 activity eluted with an apparent molecular mass of 
40 kDa. T. cruzi PLA1 seems to be a glycoprotein due to its binding to ConA-Sepharose, possesses no 
divalent  cation  requirements,  and  is  released  from  the  cell  by  digitonin  together  with  lysosomal 
markers. The physiological role played by lysosomal T. cruzi PLA1 has not been determined, though 
the authors suggest that the FA and lyso-PL products could have a possible role in pathogenesis of  
the disease. 
 
5. Plant Phospholipase A1 
 
Evidence for the existence of PLA1 in plant cells wasn’t forthcoming until relatively recently when 
the tonoplasts of Acer pseudoplatanus were shown to be able to hydrolyze sn-2-radiolabeled PC into 
radiolabeled PA and radiolabeled lyso-PC, revealing PLD and PLA1 activities, respectively [96]. Since 
then, only a few genes encoding PLA1 have been discovered. 
 
5.1. DAD1 
 
Among  the  plant  hormones  jasmonic  acid  is  considered  a  multifunctional  growth  and  stress  
regulator [97], and it is structurally similar to ―animal‖ eicosanoids. Jasmonic acid is an oxylipin 
signaling molecule and a derivative of linolenic acid (C18:3). Jasmonate has been shown to regulate or 
co-regulate a variety of processes in plants, such as responses to biotic and abiotic stresses, tendril 
coiling, fruit ripening, and the developmental maturation of stamens and pollen in Arabidopsis. The 
enzymes involved in the jasmonic acid biosynthetic pathway have been elucidated, but the last one 
discovered, a phospholipase A1 called Defective in Anther Dehiscence 1 (DAD1), was one of the most 
important because it is the enzyme responsible for the initial release of C18:3 from cellular lipids [61]. 
Starting from an Arabidopsis thaliana DAD1 mutant, the WT DAD1 gene was isolated and found to 
encode a chloroplastic 45 kDa PLA1 lipolytic enzyme. A rescued phenotype was attained by either 
complementing the mutant with WT DAD1 or after supplying exogenous jasmonic acid. The DAD1 
protein  sequence  showed  some  apparent similarities  with  fungal  lipases,  it  possessed  a  consensus 
GHSLG  motif,  and  eleven  homologous  proteins  were  identified  in  Arabidopsis  alone.  A  maltose 
binding-DAD1  fusion  protein  lacking  72  amino  acid  residues  (an  N-terminal  transit  peptide)  was 
recombinantly expressed and used to examine lipase activity. PC was the only PL tested, and the Int. J. Mol. Sci. 2011, 12                       
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activity on it was more than 80% greater than on TAG, which suggested that the C18:3 precursor for 
jasmonic acid biosynthesis is stored in cellular PLs. DAD1 is thought to be of prime importance for 
the  regulation  of  jasmonic  acid  levels.  A  PLA1  from  Capsicum  annuum  (hot  pepper)  showed  a 
considerable degree of overall sequence identity to Arabidopsis [98]. 
 
5.2. AtLCAT3 
 
In a search for A. thaliana sterol acyltransferases, one of the four enzymes found to be homologous 
to  lecithin  (PC):  Cholesterol  acyltransferases  was  determined  to  possess  PLA1  activity  [62,63]. 
AtLCAT3  (Arabidopsis  thaliana  lecithin:cholesterol  acyltransferase  3)  heterologous  expression  in 
yeast resulted in the PC, PS, and PE content to be half as much as those species in control yeast, while 
lyso-PC, lyso-PE and FFA were strongly increased. There was also a higher TAG content in the cells 
expressing AtLCAT3. AtLCAT3 fractionated with yeast microsomes, which subsequently shown to be 
able to hydrolyze various PL species, including lyso-PC and PA. However, neither acyltransferase 
activity nor TAG activity was observed with yeast microsomes expressing the enzyme. The analogous 
serine,  histidine  and  aspartic  acid residues  that  are  part  of  the  conserved  catalytic  triad  of  Homo 
sapiens  LCAT  were  shown  to  be  essential  for  activity  of  AtLCAT3.  The  physiological  role  of 
AtLCAT3 is as yet unknown. 
 
6. Bacterial PLA1 
 
The discovery of prokaryotic versions of PLA1 enzymes have up to now been confined to only one 
subclass of bacteria, the proteobacteria [68]. PLA1 from Serratia liquefaciens (PhlA) was identified as 
one of a number of proteins that are excreted to the outside environment. The impetus for studying 
PhlA was to use S. liquefaciens as a model organism to study the genetic basis for secreting proteins 
across both the periplasmic and outer membranes in gram-negative bacteria. As a result, very little 
biochemical information regarding PhlA is known. In fact, phospholipase activities of this enzyme 
were only examined against egg yolk PC imbedded in agar plates in which transparent halos were 
observed after the addition of cells expressing the enzymes. The presence of a halo around the colony 
indicated secreted phospholipase A activity, but did not discern between sn-1 and sn-2 specificity. 
PhlA encodes a 34 kDa polypeptide that has an N-terminal signal peptide. Immediately downstream 
from the PhlA gene is PhlB, which encodes a protein of 24 kDa. 
The  bacterial  exoenzyme  PhlA  was  shown  to  have  growth-phase-dependent  expression  and 
secretion, where a very low rate of PhlA production was measured during exponential growth, and a 
burst of expression and secretion was observed during stationary phase. In another report it was shown 
that PhlA expression is regulated at the level of transcription initiation, and they present sequence data 
of  two  dual  promoters  upstream  of  PhlA  that  regulate  expression  differentially  during  anaerobic 
conditions or growth-phase [99]. A subsequent study revealed that PhlA secreted from in E. coli was 
dependent on an intact flhD gene, the regulator of the flagellar/chomotaxis opero [67,100]. Mutant flhD 
strains of E. coli do not secrete recombinant PhlA, which accumulates inside the cell. Interestingly, the 
PLA1 activity of accumulated PhlA is attenuated by PhlB, which forms an enzymatically inactive 
complex with PhlA, thus neutralizing possibly lethal intracellular phospholipase activity. Int. J. Mol. Sci. 2011, 12                       
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A homologue (74% identity) of PhlA was identified in Yersinia enterocolitica (YplA) [70]. The 
YplA sequence revealed two ORFs in tandem like that of the PhlA and PhlB, but the YplB accessory 
protein was less similar to PhlB. Again, the phospholipase A activity was confirmed by testing on 
lecithin plates only. An insertion mutant of YplA was created and used in a mouse model to show that 
secreted  YplA  could  play  a  role  as  a  virulence  factor  in  the  pathogenesis  of  infection  with  
Y. enterocolitica. Neither PhlA nor YplA are homologous to bacterial lipases. 
 
7. PLA1 in Biotechnology 
 
LysoPLs  are  commonly  used  as  surfactants  in  food  technology  and  cosmetics  [101],  and  as 
components of liposomes used in drug delivery [102]. Lyso-PLs are currently produced commercially 
via their chemical synthesis [103] or via the action of extracts from porcine pancreas, which contains a 
PLA2. Viable alternative processes produce lyso-PLs enzymatically and with greater efficiency are 
being investigated, recently reviewed in [104]. 
Phospholipases are useful tools in analytical PL analysis. Though there are a number of sources of 
PLA2 commercially available at various levels of purification, no PLA1 in any form is commercially 
available,  mainly  due  to  the  difficulty  in  producing  and  purifying  the  enzyme,  especially  on  an 
industrial  scale.  The  ciliated  protozoan  Tetrahymena  thermophila  has  been  studied  as  a  potential 
natural source for PLA1 [105], which is secreted from this organism. However, high levels of PLA1 are 
undoubtedly  best  obtained  through  recombinant  expression  techniques.  Since  purified  PLA1  is 
expected  to  have  broad  industrial  applications,  a  number  of  PLA1  genes  from  a  variety  of 
microorganisms have been cloned and attempted to be expressed and purified to fulfill this need, but 
they have not been characterized.  
Serratia spp. MK1 PLA1 (PlaA), a homologue of PhlA and YplA, has been isolated from Serratia 
spp. MK1 in Korean soil and cloned and expressed in E. coli [69]. Though the enzyme is secreted 
naturally,  over-expression  resulted  in  accumulation  of  recombinant  enzyme  inside  the  cell,  and  
co-expression of its accessory protein, PlaS, was essential for cell viability and high expression levels. 
The histidine affinity tag on the recombinant protein was used in a one-step purification of the enzyme, 
which yielded under the best conditions 2.2 mg/L, the purity level was neither reported nor shown. 
Also, PLA1 in organisms adapted to lower temperatures have recently been found [106]. 
The genomic DNA and cDNA encoding a 269 amino acid PLA1 protein from Aspergillus oryzae 
have also been cloned [64]. The peptide sequence of the PLA1 showed 47% identity with that of 
mono- and diacylglycerol lipase from another fungus, Penicillium camembertii. A. oryzae PLA1 is a 
secretary  enzyme  and  it  was  recombinantly  expressed  in  the  yeast  Saccharomyces  cerevisiae  and 
purified from the extracellular broth at a level of 3.9 mg/L. Under a complex array of conditions, this 
expression  was  optimized  to  produce  approximately  2  g/L  on  an  industrial  scale  fermentor  [107]. 
However,  the  enzyme  was  only  partially  purified  from  the  culture  broth  by  ion  exchange 
chromatography and the yield was calculated based on its specific activity. Recently a PLA1 from 
Thermomyces lanuginosus expressed in Aspergillus has been commercialized as a lectinase [65].  
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8. Perspective 
 
Phospholipases  A1  are  enzymes  that  hydrolyze  phospholipids  at  the  sn-1  fatty  acids  from 
phospholipids and produces 2-acyl-lysophospholipids. This PLA1 activity is conserved in a wide range 
of organisms, but is carried out by a diverse range of enzymes. 
Despite PLA1 activities being detected in many tissues and cell lines, only a limited number of 
PLAs have been cloned and their activity and substrates identified and characterized, and even fewer 
have been studied that their function is known.  
PLA1s have been shown to have a diverse range of cellular functions including, digestive enzymes, 
central roles in membrane maintenance and remodeling via the Lands cycle of important phospholipids 
or glycolipids such as glycosylphosphatidylinositols. It is now emerging that they also regulate and 
facilitate the production of various lysophospholipid mediators, such as lysophosphatidylserine and 
lysophosphatidic acid, which in turn have multiple important biological functions. 
Thus, phospholipases A1 are an emerging class of enzyme that play important roles in the cellular 
functions including those of various diseases and pathogens that affect human health. 
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